Eric Schadt Ph.D.
Chairman of Genetics, Chief Scientific Officer
Dr. Schadt is regarded nationally and internationally as a visionary in the use of computational biology for genomic analysis. His expertise is in the generation and integration of large-scale sequence variation, molecular profiling and clinical datasets for constructing molecular networks that define disease states and link molecular and physiological processes. By developing the tools and strategies for de-convoluting large and diverse data collected from normal and disease populations, Dr. Schadt's research is providing new insights into the complexity of human disease. His work is also providing the information needed to guide drug discovery and the development of next-generation, genome-based diagnostics. He has contributed to a number of discoveries related to the genetic basis of common human diseases such as diabetes and obesity, which have been widely published in leading, scientific journals. Dr. Schadt's knowledge and experience with translational medicine, managing big datasets and investigating the structure and function of genomes make him a highly sought-after collaborator, speaker and advisor. In 2012, he directed or participated in several research collaborations that resulted in more than 35 high-impact scientific publications that year. He is well known for his lively and engaging lecture style and his ability to communicate the concepts and applications of genomics to a wide range of audiences. In 2012, Dr. Schadt's documentary film, "The New Biology", received the Master Series Award from the prestigious CINE Institute.